Lung Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Lung
| Protocol | EA5231 |
|---|---|
| Cancer Type: | Lung |
| Fast Facts |
EA5231, A Randomized Phase III Trial of Checkpoint blockade in Lung cancEr patients in the Adjuvant setting based on pathologic Response following neoadjuvant therapy (CLEAR) (NCT06732401)
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | COG ARAR2331 |
|---|---|
| Cancer Type: | Lung-Pleuropulmonary Blastoma |
| Fast Facts |
Prospective Treatment of Types I, II and III Pleuropulmonary Blastoma (PPB) A COG Groupwide Phase 3 Study
Patients must be ≤ 21 years of age at the time of study enrollment.
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
